<DOC>
	<DOCNO>NCT00207844</DOCNO>
	<brief_summary>Septic shock frequent syndrome 45 % mortality rate despite intensive care unit ( ICU ) care , free radical may play key role , &gt; 40 % decrease plasma selenium concentration observe . Selenium trace element indirect enzymatic anti-oxidant , direct oxidant property . High dose sodium selenite administration could increase antioxidant cell capacity , reduce inflammation direct paradoxical pro-oxidative effect . We conduct study evaluate effect selenium treatment comparison placebo , septic shock patient . Efficacy evaluate weaning time catecholamine .</brief_summary>
	<brief_title>Selenium , Sodium Selenite , Treatment Septic Shock</brief_title>
	<detailed_description>Septic shock - uncontrolled systemic host response invasive infection - , lead multiple organ failure , public health issue frequency ( &gt; 1/1000 inhabitant per year ) , cost 45 % mortality rate , remain high despite improvement make ICU past 20 year . His physiopathology well understood increase data support key role free radical , 40 % plasma selenium concentration decrease maybe associate increased morbidity mortality . Meanwhile , past 30 year , research conduct essential trace element selenium requirement key antioxidant enzyme , 21st aa selenocystein , also potentially toxic , pro-oxidant property . In septic shock , property may useful , antioxidant enzymatic increase cell defense especially endothelial cell , direct pro-oxidant action decrease genomic response , especially phagocytic cell . The objective study evaluate effect high dose selenium administration , selenite , pro-oxydant initial dose follow anti-oxidant dose severe septic shock patient documented infection . The initial dose choose high dose selenium , sodium selenite , estimate without severe adverse effect healthy people one-day ingestion . The patient randomize receive either placebo selenite high initial dose follow low dos 9-day period . The efficacy evaluate weaning time catecholamine , special attention 6-month mortality rate first secondary end point .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Selenious Acid</mesh_term>
	<mesh_term>Sodium Selenite</mesh_term>
	<criteria>Hospitalization ICU Severe document infection Ventilation Circulatory failure require high dose catecholamine IGS II score &gt; 25 inclusion Informed write consent Pregnancy End phase chronic disease Limitation care Shock due urinary infection without bacteriemia Peritonitis related peritoneal dialysis trauma Preliminary circulatory failure Participating another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Selenium</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Septic shock</keyword>
	<keyword>Sodium selenite</keyword>
</DOC>